Aflibercept for central retinal vein occlusions: long-term outcomes of a 'Treat-and-Extend' regimen.

Damian JaggiThanoosha NagamanySebastian WolfMartin Sebastian ZinkernagelFlorian M Heussen

Published in: BMJ open ophthalmology (2024)

The T&E regimen for CRVO shows sustained visual improvements and reduced CST over time. Patients maintained stable visual gains for many years, demonstrating the effectiveness of this treatment approach. However, no control group was available to compare our T&E regimen with other strategies.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
randomized controlled trial
systematic review
peritoneal dialysis
prognostic factors
patient reported outcomes